NYSE : MED

Medifast, Inc.

$13.15 USD

$3.41 (35.01%)

Volume
509.79K
Average Volume
190.53K
Market Capitalization
$146.22M
P/E Ratio
-5.64
Dividend Yield
0.00%
Price Target
$12.00
Year High
$15.11
Year Low
$9.22
Day High
Day Low
Payout Ratio
-$0.01
Current Ratio
$4.86
Company Overview

NYSE

Nicholas Johnson

Specialty Business Services

Industrials

MED

380

US

USD

410 581 8042

58470H101

0000910329

Liquidity Metrics

0.14

4.86

4.35

1.73

-0.01

Sales & Valuation

$385.79M

0.46

0.74

36.44

0.36

Profitability

-$1.7

-$18.67M

-8.08%

-4.41%

-12.68%

-9.83%

P/E Metrics

-5.64

0.01

0.01

Analyst Price Target & Rating

$12.00

$12.00

$12.00

Neutral

3/5

12 Analysts

9.58%

Financial Health Scores

3.64

3/9

$160.47M

$260.4M

$64.02M

-$11.82M

Key Metrics (TTM)

$64.01M

0.20

-13.04

4.86

-12.68%

-8.71%

-23.74%

3.71%

79 days

Company Executives
Name Title
James Maloney Chief Financial Officer
Nicholas Johnson CEO & President
Steven Zenker Vice President of Investor Relations
Claudia C. Greninger Chief Human Resources Officer
Jonathan Barrett MacKenzie Vice President of Finance & Chief Accounting Officer
Poll Results

No votes yet today — be the first to share your view!

About Medifast, Inc. (NYSE:MED) Stock

Medifast, Inc., through its various divisions, develops and provides a range of consumable health and nutritional items tailored for weight loss, weight management, and general wellness. These products are distributed across the United States and the Asia-Pacific region. Their extensive portfolio encompasses snack bars, savory bites, cereals, drinks, substantial meal choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, baked goods, and soups. These offerings are marketed under proprietary brands like OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home. The company facilitates sales primarily through direct e-commerce transactions. Established in 1980, Medifast, Inc. maintains its corporate headquarters in Baltimore, Maryland. ...

Medifast, Inc. (MED) Q2 2026 Earnings Call Transcript

2026-08-04 00:19:58

Medifast, Inc. (MED) Q2 2026 Earnings Call Transcript

Medifast Q2 Earnings Call Highlights

2026-08-03 20:05:09

Medifast NYSE: MED reported second-quarter 2026 revenue of $76.4 million, down 27.6% from a year earlier, as its active earning coach base continued to decline amid the rapid adoption of GLP-1 medications across the traditional weight-loss category. The company posted a net loss of $3.1 million, or $0.28 per diluted share, compared with net income of $2.5 million, or $0.22 per share, in the prior-year quarter.

Medifast (MED) Reports Q2 Loss, Beats Revenue Estimates

2026-08-03 18:46:11

Medifast (MED) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.67. This compares to earnings of $0.04 per share a year ago.

Medifast Announces Second Quarter 2026 Financial Results

2026-08-03 16:05:00

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy, today reported results for the second quarter ended June 30, 2026. Second Quarter 2026 Revenue: $76.4 million, with revenue per active earning coach of $6,529 Independent active earning coaches of 11,700 Net loss of $3.1 million or $0.28 loss per diluted share ("EPS") Cash, Cash Equivalents, and Investment Securities of $169.8 million wit.

Medifast Stock to Post Q2 Earnings: What Investors Should Know

2026-07-29 12:36:06

MED's Q2 results are likely to face continued pressure from GLP-1 adoption and a smaller coach base, while productivity gains and cost actions may have helped offset some challenges.

Medifast (MED) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

2026-07-27 11:03:25

Medifast (MED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2026

2026-07-20 16:05:00

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy, will announce financial results for the quarter ended June 30, 2026 on Monday, August 3, 2026, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Nick Johnson, Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The.

Will Medifast's Trilivy Launch Unlock a New Growth Chapter?

2026-07-20 11:31:08

Medifast's Trilivy expands beyond weight management with metabolic health support, personalized coaching and a structured three-phase journey.

Frequently Asked Questions

What is the current Medifast, Inc. (MED) stock price?

Medifast, Inc.(NYSE:MED) stock price is $13.15 in the last trading session. During the trading session, MED stock reached the peak price of $15.11 while $9.22 was the lowest point it dropped to. The percentage change in MED stock occurred in the recent session was 35.01% while the dollar amount for the price change in MED stock was $3.41.

MED's industry and sector of operation?

The NYSE listed MED is part of Specialty Business Services industry that operates in the broader Industrials sector.

Who are the executives of MED?

James Maloney | Chief Financial Officer
Nicholas Johnson | CEO & President
Steven Zenker | Vice President of Investor Relations
Claudia C. Greninger | Chief Human Resources Officer
Jonathan Barrett MacKenzie | Vice President of Finance & Chief Accounting Officer

How many employees does MED have?

Number of MED employees currently stands at 380. MED operates from 1501 S. Clinton Street, Baltimore, MD 21224, US.

Link for MED official website?

Official Website of MED is: https://medifastinc.com

How do I contact MED?

MED could be contacted at phone #410 581 8042 and can also be accessed through its website. MED operates from 1501 S. Clinton Street, Baltimore, MD 21224, US.

How many shares of MED are traded daily?

The average number of MED shares traded daily for last 3 months was 190.53K.

What is the market cap of MED currently?

The market value of MED currently stands at $146.22M with its latest stock price at $13.15